Tastend von Gott reden : drei systematisch-theologische Antrittsvorlesungen aus Bern

Nach Gott tasten ist die Grundbewegung, die die drei in diesem Band versammelten Vorlesungen verknüpft und für die Paul Klees «Engel, noch tastend» zum hermeneutischen Leitbild wird. Torsten Meireis, inspiriert durch Karl Barth, reflektiert inmitten religiöser und weltanschaulicher Pluralität ein moralisches Verhalten, das dem Handeln des in Jesus Christus offenbaren Gottes entspricht. Wegweisend wird ihm dabei ein dreifacher Begriff des Guten: unverfügbares, intendiertes und realisiertes Gutes. Um angesichts des Sinnverlustes religiöser Rede dennoch nicht von Gott zu schweigen, plädiert Andreas Krebs, angeregt durch Ludwig Wittgensteins Spätphilosophie, für ein «halbes Sagen, halbes Verstehen», das sich in der Nähe zur Sprache der Poesie weiss – eine Gottesrede, die sich ihrer selbst nicht mehr sicher ist und gerade so Gott Gewicht zu geben sucht. Als Baustein einer um den Eigennamen kreisenden Eschatologie entwirft Magdalene L. Frettlöh die Hoffnung auf eine als neuschöpferischen göttlichen Namensruf an die Toten verstandene Auferweckung. Diese schliesst Rettung wie Verwandlung des irdischen Lebens ein.

Anti-judaistische Passionsgeschichten? Die biblischen Passionsgeschichten und ihre Wirkungsgeschichte in der neutestamentlichen Diskussion am Beispiel von Matthäus 27,25

Der Artikel befasst sich mit der Wirkungsgeschichte von Matthäus 27,25, dem sogenannten Blutruf und diskutiert, wie mit dieser Bibelstelle sowie anderen schwierigen Texten des Bibel im Rahmen von Gottesdienst, Liturgie und Gemeinde umgegangen werden soll.

[Collagenase injection in Dupuytren's disease, evaluation of the ultrasound assisted technique].

Since October 2011, the enzymatic lysis of Dupuytren's cord was introduced in Switzerland (Xiapex(®), Auxilium Pharmaceuticals, Pfizer). Here we present our first university experience and underline the major role of ultrasound during the injection. Between December 2011 and February 2013, 52 injections were performed to eliminate 43 Dupuytren's cords in 33 patients. The mean age of the patients was 64.4 ± 8.5 years. Complications were documented for each patient. Before, directly after and after a minimum of 6 months post-injection, the contracture of the treated joint was measured with use of a goniometer. The DASH score was evaluated after a minimum of 6 months and the patients were asked to subjectively evaluate the outcome of the treatment (very good, good, mild, poor) and whether they would reiterate it if necessary. Four skin defects, one lymphangitis, and one CRPS were responsible for a complication rate of 18%. There was no infection and no tendon rupture in the series. The mean MCP joint contracture was respectively 36.8 ± 27.4°, 3.5 ± 7.8° (gain of mobility compared to the preoperative situation 33.3°, P<0.001), and 8.4 ± 13.9° (gain 28.4°, P<0.001) respectively before, just after and at the long-term clinical control. The mean PIP joint contracture was respectively 36.5 ± 29.1°, 5.9 ± 6.7° (gain 30.6°, P<0.001), and 15.1 ± 13.8° (gain 21.4°, P<0.001) respectively before injection, just after and at the long-term clinical control. The DASH score decreased from 24 ± 14 to 7 ± 9 (P<0.001). Eighty-one per cent of the patients were satisfied or very satisfied of the treatment. All but two would reiterate the treatment if necessary. Ultrasound is able to target the injection of collagenase in order to reduce complications. The short-term results of this non-invasive therapy are very promising however comparison with conventional procedures is difficult as the long-term results are lacking.

The Freedom SOLO bovine pericardial stentless valve

Abstract: The third-generation bovine pericardium Freedom SOLO (FS) stentless valve emerged in 2004 as a modified version of the Pericarbon Freedom stentless valve and as a very attractive alternative to stented bioprostheses. The design, choice of tissue, and anticalcification treatment fulfill most, if not all, requirements for an ideal valve substitute. The FS combines the single-suture, subcoronary implantation technique with the latest-generation bovine pericardial tissue and novel anticalcification treatment. The design allows imitation of the native healthy valve through unrestricted adaption to the patient's anatomy, reproducing a normal valve/root complex. However, despite hemodynamic performance superior to stented valves, we are approaching a critical observation period as superior durability, freedom from structural valve deterioration, and nonstructural failure has not been proven as expected. However, optimal performance and freedom from structural valve deterioration depend on correct sizing and perfect symmetric implantation, to ensure low leaflet stress. Any malpositioning can lead to tissue fatigue over time. Furthermore, the potential for better outcomes depends on optimal patient selection and observance of the limitations for the use of stentless valves, particularly for the FS. Clearly, stentless valve implantation techniques are less reproducible and standardized, and require surgeon-dependent experience and skill. Regardless of whether or not stentless valve durability surpasses third-generation stented bioprostheses, they will continue to play a role in the surgical repertoire. This review intends to help practitioners avoid pitfalls, observe limitations, and improve patient selection for optimal long-term outcome with the attractive FS stentless valve.